New combo aims to shed fat, not muscle, in weight loss fight
NCT ID NCT05933499
Summary
This study is testing if using two investigational drugs together—tirzepatide and bimagrumab—alongside a lifestyle program leads to better body composition changes than either drug alone in adults with obesity. The goal is to see if the combination helps people lose more fat while preserving important muscle mass and bone health over one year. Researchers will measure changes in body fat, muscle, and insulin sensitivity in 63 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.